• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖、糖尿病和脂肪性肝病的小鼠模型中肝脏能量代谢的改变。

Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.

机构信息

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; German Center for Diabetes Research, Partner Düsseldorf, München-Neuherberg, Germany.

Department of Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria; Christian Doppler Laboratory for Insulin Resistance, Department of Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria.

出版信息

EBioMedicine. 2023 Aug;94:104714. doi: 10.1016/j.ebiom.2023.104714. Epub 2023 Jul 16.

DOI:10.1016/j.ebiom.2023.104714
PMID:37454552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10384226/
Abstract

BACKGROUND

Disturbed hepatic energy metabolism contributes to non-alcoholic fatty liver (NAFLD), but the development of changes over time and obesity- or diabetes-related mechanisms remained unclear.

METHODS

Two-day old male C57BL/6j mice received streptozotocin (STZ) or placebo (PLC) and then high-fat (HFD) or regular chow diet (RCD) from week 4 (W4) to either W8 or W16, yielding control [CTRL = PLC + RCD], diabetes [DIAB = STZ + RCD], obesity [OBES = PLC + HFD] and diabetes-related non-alcoholic steatohepatitis [NASH = STZ + HFD] models. Mitochondrial respiration was measured by high-resolution respirometry and insulin-sensitive glucose metabolism by hyperinsulinemic-euglycemic clamps with stable isotope dilution.

FINDINGS

NASH showed higher steatosis and NAFLD activity already at W8 and liver fibrosis at W16 (all p < 0.01 vs CTRL). Ballooning was increased in DIAB and NASH at W16 (p < 0.01 vs CTRL). At W16, insulin sensitivity was 47%, 58% and 75% lower in DIAB, NASH and OBES (p < 0.001 vs CTRL). Hepatic uncoupled fatty acid oxidation (FAO)-associated respiration was reduced in OBES at W8, but doubled in DIAB and NASH at W16 (p < 0.01 vs CTRL) and correlated with biomarkers of unfolded protein response (UPR), oxidative stress and hepatic expression of certain enzymes (acetyl-CoA carboxylase 2, Acc2; carnitine palmitoyltransferase I, Cpt1a). Tricarboxylic acid cycle (TCA)-driven respiration was lower in OBES at W8 and doubled in DIAB at W16 (p < 0.0001 vs CTRL), which positively correlated with expression of genes related to lipolysis.

INTERPRETATION

Hepatic mitochondria adapt to various metabolic challenges with increasing FAO-driven respiration, which is linked to dysfunctional UPR, systemic oxidative stress, insulin resistance and altered lipid metabolism. In a diabetes model, higher TCA-linked respiration reflected mitochondrial adaptation to greater hepatic lipid turnover.

FUNDING

Funding bodies that contributed to this study were listed in the acknowledgements section.

摘要

背景

非酒精性脂肪肝(NAFLD)与肝能量代谢紊乱有关,但随着时间的推移,这种变化的发展以及肥胖症或糖尿病相关的机制仍不清楚。

方法

2 天大的雄性 C57BL/6j 小鼠接受链脲佐菌素(STZ)或安慰剂(PLC),然后从第 4 周(W4)开始给予高脂肪(HFD)或普通饮食(RCD),持续至第 8 周(W8)或第 16 周(W16),得到对照[CTRL=PLC+RCD]、糖尿病[DIAB=STZ+RCD]、肥胖症[OBES=PLC+HFD]和糖尿病相关非酒精性脂肪性肝炎[NASH=STZ+HFD]模型。通过高分辨率呼吸测量法测定线粒体呼吸,通过稳定同位素稀释的高胰岛素-正常血糖钳夹技术测定胰岛素敏感的葡萄糖代谢。

结果

NASH 在 W8 时已显示出更高的脂肪变性和 NAFLD 活性,在 W16 时出现肝纤维化(均 p<0.01 比对照)。气球样变增加在 W16 时的 DIAB 和 NASH 中(p<0.01 比对照)。在 W16 时,DIAB、NASH 和 OBES 的胰岛素敏感性分别降低了 47%、58%和 75%(p<0.001 比对照)。OBES 在 W8 时脂肪酸氧化(FAO)相关的去偶呼吸减少,但 DIAB 和 NASH 在 W16 时增加了一倍(p<0.01 比对照),与未折叠蛋白反应(UPR)、氧化应激和某些酶(乙酰辅酶 A 羧化酶 2,Acc2;肉碱棕榈酰转移酶 I,Cpt1a)的肝表达相关。OBES 在 W8 时三羧酸循环(TCA)驱动的呼吸减少,在 DIAB 时增加了一倍(p<0.0001 比对照),这与与脂肪分解相关的基因表达呈正相关。

结论

肝脏线粒体通过增加 FAO 驱动的呼吸来适应各种代谢挑战,这与功能失调的 UPR、全身氧化应激、胰岛素抵抗和改变的脂质代谢有关。在糖尿病模型中,更高的 TCA 相关呼吸反映了线粒体对更大的肝脂质周转率的适应。

资金

参与本研究的资助机构在致谢部分列出。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/5eced665acdf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/12dd7845c612/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/840fe2a265d3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/9229b50c7aea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/a6be722abbde/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/8408acbc2908/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/d87ee8743483/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/5eced665acdf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/12dd7845c612/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/840fe2a265d3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/9229b50c7aea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/a6be722abbde/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/8408acbc2908/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/d87ee8743483/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38b/10384226/5eced665acdf/gr7.jpg

相似文献

1
Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.肥胖、糖尿病和脂肪性肝病的小鼠模型中肝脏能量代谢的改变。
EBioMedicine. 2023 Aug;94:104714. doi: 10.1016/j.ebiom.2023.104714. Epub 2023 Jul 16.
2
Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.整合组学分析揭示高果糖玉米糖浆在肥胖型非酒精性脂肪肝病中的作用。
Metabolism. 2023 Jul;144:155552. doi: 10.1016/j.metabol.2023.155552. Epub 2023 Mar 28.
3
P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.P2Y2R 缺乏通过诱导 AMPK 和 PGC-1α 减少脂肪生成和增强脂肪酸β氧化来改善高脂肪饮食喂养小鼠的肝脂肪变性。
Int J Mol Sci. 2021 May 24;22(11):5528. doi: 10.3390/ijms22115528.
4
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.肝 CPT1A 基因治疗可减少小鼠饮食诱导的肝脂肪变性,并突出了人类非酒精性脂肪性肝病的潜在脂质生物标志物。
FASEB J. 2020 Sep;34(9):11816-11837. doi: 10.1096/fj.202000678R. Epub 2020 Jul 15.
5
Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet.高脂肪高蔗糖饮食诱导的脂肪性肝炎小鼠肝代谢适应性和脂肪组织扩张改变。
J Nutr Biochem. 2021 Mar;89:108559. doi: 10.1016/j.jnutbio.2020.108559. Epub 2020 Nov 29.
6
Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.伴侣蛋白通过协助沉默调节蛋白3控制脂肪酸氧化来对抗饮食诱导的非酒精性脂肪性肝病。
Diabetologia. 2023 May;66(5):913-930. doi: 10.1007/s00125-023-05869-9. Epub 2023 Jan 24.
7
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.一项对纤维化非酒精性脂肪性肝炎小鼠模型进行的全身、组织和细胞生理学纵向研究,该模型高度逼真地模拟了人类病情。
Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G666-G680. doi: 10.1152/ajpgi.00213.2016. Epub 2017 Feb 23.
8
Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.缺乏氯离子通道蛋白2可减轻高脂饮食诱导的胰岛素抵抗和非酒精性脂肪性肝病。
Cell Physiol Biochem. 2018;45(6):2187-2198. doi: 10.1159/000488164. Epub 2018 Mar 10.
9
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.尽管三羧酸循环活性增加,但脂肪性肝炎中仍会发生脂毒性。
Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94. doi: 10.1152/ajpendo.00492.2015. Epub 2016 Jan 26.
10
Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.Nrg4 可促进燃料氧化和健康的脂肪细胞因子谱,改善饮食诱导的代谢紊乱。
Mol Metab. 2017 Jun 21;6(8):863-872. doi: 10.1016/j.molmet.2017.03.016. eCollection 2017 Aug.

引用本文的文献

1
Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease?线粒体功能改变:代谢功能障碍相关脂肪性肝病与慢性肾脏病之间治疗策略的线索?
Front Nutr. 2025 Jun 13;12:1613640. doi: 10.3389/fnut.2025.1613640. eCollection 2025.
2
Stress Management: How the Endoplasmic Reticulum Mitigates Protein Misfolding and Oxidative Stress by the Dual Role of Glutathione Peroxidase 8.应激管理:内质网如何通过谷胱甘肽过氧化物酶8的双重作用减轻蛋白质错误折叠和氧化应激
Biomolecules. 2025 Jun 10;15(6):847. doi: 10.3390/biom15060847.
3
The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.
1990年至2021年非酒精性脂肪性肝病(包括肝硬化)对老年人的全球影响及疾病负担的未来预测。
PLoS One. 2025 Jun 25;20(6):e0325961. doi: 10.1371/journal.pone.0325961. eCollection 2025.
4
Transcriptomic and epigenomic signatures of liver metabolism and insulin sensitivity in aging mice.衰老小鼠肝脏代谢和胰岛素敏感性的转录组学和表观基因组学特征
Mech Ageing Dev. 2025 Jun;225:112068. doi: 10.1016/j.mad.2025.112068. Epub 2025 May 3.
5
Ketone body metabolism and cardiometabolic implications for cognitive health.酮体代谢及其对认知健康的心脏代谢影响。
NPJ Metab Health Dis. 2024;2. doi: 10.1038/s44324-024-00029-y. Epub 2024 Oct 11.
6
Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD.ω-3 脂肪酸补充剂的脂类种类对 MASLD 患者肝脏脂肪堆积的影响。
Physiol Res. 2024 Aug 31;73(Suppl 1):S295-S320. doi: 10.33549/physiolres.935396. Epub 2024 Jul 17.
7
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment.MASLD 中的肠道微生物代谢产物:线粒体功能障碍在发病机制和治疗中的意义。
Hepatol Commun. 2024 Jul 5;8(7). doi: 10.1097/HC9.0000000000000484. eCollection 2024 Jul 1.
8
Ginsenoside Rb1 reduces oxidative/carbonyl stress damage and dysfunction of RyR2 in the heart of streptozotocin-induced diabetic rats.人参皂苷 Rb1 可减轻链脲佐菌素诱导的糖尿病大鼠心脏中 RyR2 的氧化/羰基应激损伤和功能障碍。
BMC Cardiovasc Disord. 2024 Jul 3;24(1):333. doi: 10.1186/s12872-024-04005-8.
9
Updated mechanisms of MASLD pathogenesis.MASLD 发病机制的更新机制。
Lipids Health Dis. 2024 Apr 22;23(1):117. doi: 10.1186/s12944-024-02108-x.